Abstract
Berberis kaschgarica Rupr. fruits (BKF) can reduce blood pressure, regulate blood lipid levels, and exert anti-inflammatory and anti-oxidative effects. Additionally, alkaloids are among the active components in BKF. Sensitive and selective high-performance liquid chromatography with mass spectrometry, network pharmacology, and bioinformatic analysis was conducted. We identified 544 metabolites and 105 secondary metabolites from BFK. Among the secondary metabolites, 24 were alkaloids. Moreover, there were 583 potential drug targets and 4,481 human anti-atherosclerosis targets. Finally, 366 intersecting targets of BFK against atherosclerosis were identified. These targets were enriched in 546 terms in biological processes, 48 terms in cell components, 121 terms in molecular functions, and 36 signaling pathways. Notably, 18 of the 24 alkaloids were fat-soluble alkaloids (FSA), and the remaining 6 were water-soluble alkaloids (WSA). Because oxyberberine (OBB) was predicted to have an ideal anti-atherosclerosis effect and was further studied. We established four intervention groups: FSA, WSA, total alkaloids (TA), and OBB. The effects of these alkaloids on caspase-11-induced pyroptosis and TLR4-induced inflammation in LPS-stimulated mouse macrophages in vitro were explored. The anti-pyroptosis results demonstrated significant evaluation in caspase-11, caspase-1, IL-1β, IL-18, and, GSDMD. Additionally, there were significant decreases in MMP3 and MMP9 in the supernatant, as well as the expression of TLR4 and pSTAT3. Conclusively, BKF contains numerous effective components, making it a valuable natural medicinal material with substantial developmental and utilitarian potential. In in vitro experiments, the alkaloids from BKF can reduce the LPS-induced expression of caspase-11 and GSDMD. Compared with previous studies on BKF, which had gaps in systematic identification of bioactive subtypes via basic colorimetry and unclear anti-AS mechanisms. our study advances research by using UPLC-MS/MS for the first time to identify 544 metabolitesin BKF, establishing a comprehensive metabolite profile and integrating network pharmacology and in vitro assays to first link BKF alkaloids to regulating caspase-11-mediated pyroptosis and TLR4-induced inflammation. Moreover, our findings contribute to compositional innovation, mechanistic breakthroughs, and translational value.
Similar content being viewed by others
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- BKF:
-
Berberis kaschgarica Rupr. fruits
- FSA:
-
Fat-soluble alkaloids
- OBB:
-
Oxyberberine
- TA:
-
Total alkaloids
- WSA:
-
Water-soluble alkaloids
- BKF:
-
Berberis kaschgarica Rupr. fruits
- FSA:
-
Fat-soluble alkaloids
- OBB:
-
Oxyberberine
- TA:
-
Total alkaloids
- WSA:
-
Water-soluble alkaloids
References
Liao, C. P. et al. Investigation of the metabolites of five major constituents from Berberis amurensis in normal and pseudo germ-free rats. Chin. J. Nat. Med. 19, 758–771. https://doi.org/10.1016/s1875-5364(21)60082-1 (2021).
Feng, T. et al. The complete chloroplast genome of Berberis weiningensis (Berberidaceae), an endemic and traditional Chinese medicinal herb. Mitochondrial DNA B Resour. 6, 1175–1177. https://doi.org/10.1080/23802359.2021.1901625 (2021).
Wang, Y. Study on Chemical Constituents of Berries (Berberis kaschgarica Rupr). J. Tarim Univ. 21, 19–22 (2009).
Zhao, J. & Yang, L. Preliminary identification of anthocyanins in Berberis fruits in Xinjiang. China Food Additives. 04, 121–124 (2011).
Sun, Y. Quality control of Berberis nigricans and application of near infrared spectroscopy in quality control (Xinjiang Medical University, 2013).
Huang, J. Study on Antioxidant Characteristic of Anthocyanidin from Microencapsulated Berberis kaschgarica Rupr. J. Hui Agricultural Sci. 39, 3244–3246 (2011).
Maierdan, Y. et al. Relaxation effects of Berberis Kaschgarica Rupr. Fruit Water Extract on Isolated Thoracic Aortic Rings of Rats. Chin. Traditional Patent Med. 41, 448–450. https://doi.org/10.3969/j.issn.1001-1528.2019.02.041 (2019).
Gui, T., Shimokado, A., Sun, Y., Akasaka, T. & Muragaki, Y. Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators Inflamm. 2012 (693083). https://doi.org/10.1155/2012/693083 (2012).
Bobryshev, Y. V., Ivanova, E. A., Chistiakov, D. A., Nikiforov, N. G. & Orekhov, A. N. Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis. Biomed. Res. Int. 2016 (9582430). https://doi.org/10.1155/2016/9582430 (2016).
Tajbakhsh, A., Rezaee, M., Kovanen, P. T. & Sahebkar, A. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms. Pharmacol. Ther. 188, 12–25. https://doi.org/10.1016/j.pharmthera.2018.02.003 (2018).
Su, G. & Guan, X. Effects of macrophage apoptosis, pyroptosis and ferroptosis on the progression of atherosclerotic plaque. Int. J. Immunol. 43, 336–341. https://doi.org/10.3760/cma.j.issn.1673-4394.2020.03.018 (2020).
Li, M. H. et al. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy. Eur. J. Pharmacol. 728, 67–76. https://doi.org/10.1016/j.ejphar.2014.01.061 (2014).
Zhao, G. L. et al. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress. Acta Pharmacol. Sin. 37, 354–367. https://doi.org/10.1038/aps.2015.136 (2016).
Miao, M. & Han, Y. Research progress of pyroptosis in coronary atherosclerosis. Int. J. Cardiovasc. Disease. 50, 144–147 (2023).
Gu, Y., Tang, Z. & Wu, Y. The different roles of Inflammasomes/caspases pathway obout pyroptosis and cell apoptosis in atherosclerosis. China J. Traditional Chin. Med. 28, 1378–1382 (2022).
Zhao, Z. & Ma, Y. Predictive effect of pyroptosis-related factors expression on atherosclerotic cardiovascular disease in patients with type 2 diabetes. Chin. J. health Lab. Technol. 33, 323–326331 (2023).
Zeng, X. et al. Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression. J. Transl Med. 16, 106. https://doi.org/10.1186/s12967-018-1479-6 (2018).
Gwon, W. G. et al. Sargachromenol protects against vascular inflammation by preventing TNF-alpha-induced monocyte adhesion to primary endothelial cells via inhibition of NF-kappaB activation. Int. Immunopharmacol. 42, 81–89. https://doi.org/10.1016/j.intimp.2016.11.014 (2017).
Hiller, J. et al. STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC. J. Invest. Dermatol. 138, 711–714. https://doi.org/10.1016/j.jid.2017.09.035 (2018).
Li, Y. et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Atherosclerosis 259, 75–82. https://doi.org/10.1016/j.atherosclerosis.2017.02.003 (2017).
Peterson, J. T., Li, H., Dillon, L. & Bryant, J. W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 46, 307–315. https://doi.org/10.1016/s0008-6363(00)00029-8 (2000).
Konstantino, Y. et al. Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease. Biomarkers 14, 118–129. https://doi.org/10.1080/13547500902765140 (2009).
Rasic, S., Rebic, D., Hasic, S., Rasic, I. & Delic Sarac, M. Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome. Mediators Inflamm. 2015 (614357). https://doi.org/10.1155/2015/614357 (2015).
Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. NucleicAcids Res. 53. D672–D677. https://doi.org/10.1093/nar/gkae909 (2025).
Kanehisa, M. & Goto, S. K. E. G. G. Kyoto Encyclopedia of Genes and Genomes. Nucleic AcidsRes. 28, 27–30 (2000). http://www.genome.ad.jp/kegg/
Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. ProteinSci 28, 1947–1951. https://doi.org/10.1002/pro.3715 (2019).
Shi, X. & Xu, S. Research progress of pyroptosis and diseases related to human beings and animals. J. Tarim Univ. 35, 1–11 (2023).
Wang, B., Wang, T., Zhang, L., Zhang, S. & Zhang, D. Research progress of inflammatory corpuscles and pyroptosis in intestinal homeostasis. China J. Immunol. 39, 1337–1341 (2023).
Wu, D., Yang, J. & Zhang, C. Application progress of LC-MS in Polygonaceae Chinese medicinal materials. China Pharm. 25, 2179–2181 (2014). doi:CNKI:SUN:ZGYA.0.2014-23-027.
Alifeire, A. et al. Effects of Berberis Kashi extract on blood lipid and inflammation-related indexes in atherosclerotic rats. Zhongnan Pharm. 20, 1052–1056 (2022).
Sinning, D., Leistner, D. M. & Landmesser, U. [Impact of lipid metabolism parameters on the development and progression of coronary artery disease: An update]. Herz 41, 273–280. https://doi.org/10.1007/s00059-016-4430-8 (2016).
Zhang, H. et al. Programmed death of macrophages in atherosclerosis. China J. Mod. Med. 33, 43–49 (2023).
Xiao, F., Gong, L. & Zhao, S. Discussion on the correlation between atherosclerosis and mitochondrial autophagy based on the theory of phlegm and blood stasis generating wind. Chin. Med. Herald. 29, 105–107116 (2023).
Wang, J. Research progress on the relationship between mitochondrial dynamics/autophagy and the stability of atherosclerotic plaques. Mod. Med. Health. 38, 3318–33213325 (2022).
He, L. et al. PINK1/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMPKalpha and exacerbates atherosclerotic lesions. J. Cell. Physiol. 234, 8668–8682. https://doi.org/10.1002/jcp.27527 (2019).
Peng, X. et al. Effects of NIX-mediated mitophagy on ox-LDL-induced macrophage pyroptosis in atherosclerosis. Cell. Biol. Int. 44, 1481–1490. https://doi.org/10.1002/cbin.11343 (2020).
Li, C. et al. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-kappaB pathway. Pharmacol. Res. 152, 104603. https://doi.org/10.1016/j.phrs.2019.104603 (2020).
Zhao, R. et al. Oxyberberine Prevented Lipopolysaccharide-Induced Acute Lung Injury through Inhibition of Mitophagy. Oxid Med Cell Longev 2021, 6675264, (2021). https://doi.org/10.1155/2021/6675264
Dou, Y. et al. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. Biomed. Pharmacother. 137, 111312. https://doi.org/10.1016/j.biopha.2021.111312 (2021).
Anwar, M. A. et al. Isolation of Oxyberberine and β-Sitosterol from Berberis lycium Royle Root Bark Extract and In Vitro Cytotoxicity against Liver and Lung Cancer Cell Lines. Evid. Based Complement. Alternat Med. 2020, 2596082. https://doi.org/10.1155/2020/2596082 (2020).
Yuan, Y., Dong, F. X., Liu, X., Xiao, H. B. & Zhou, Z. G. Liquid Chromatograph-Mass Spectrometry-Based Non-targeted Metabolomics Discovery of Potential Endogenous Biomarkers Associated With Prostatitis Rats to Reveal the Effects of Magnoflorine. Front. Pharmacol. 12, 741378. https://doi.org/10.3389/fphar.2021.741378 (2021).
Zhao, F. et al. Magnoflorine Alleviates M1 Polarized Macrophage-Induced Intervertebral Disc Degeneration Through Repressing the HMGB1/Myd88/NF-κB Pathway and NLRP3 Inflammasome. Front. Pharmacol. 12, 701087. https://doi.org/10.3389/fphar.2021.701087 (2021).
Sun, Z. et al. Magnoflorine Suppresses MAPK and NF-κB Signaling to Prevent Inflammatory Osteolysis Induced by Titanium Particles In Vivo and Osteoclastogenesis via RANKL In Vitro. Front. Pharmacol. 11, 389. https://doi.org/10.3389/fphar.2020.00389 (2020).
Liu, Y. T. et al. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab. Dispos. 38, 1779–1784. https://doi.org/10.1124/dmd.110.033936 (2010).
Zuo, F., Nakamura, N., Akao, T. & Hattori, M. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab. Dispos. 34, 2064–2072. https://doi.org/10.1124/dmd.106.011361 (2006).
Arumugam, M. K. et al. Beneficial Effects of Betaine: A Comprehensive Review. Biology (Basel). 10 https://doi.org/10.3390/biology10060456 (2021).
Hu, S. et al. Simvastatin inhibits apoptosis by up-regulating the expression of Bcl-2 protein in vascular wall of atherosclerotic rats. J. South. Med. Univ. 37, 1456–1460. https://doi.org/10.3969/j.issn.1673-4254.2017.11.05 (2017).
Chen, Y., Ding, H., Li, G. & Wang, L. Effects of Ad-FLT-1/PC on apoptosis and oxidative stress in diabetic nephropathy atherosclerotic rats. Chin. J. Nephrol. 33, 770–774. https://doi.org/10.3760/cma.j.issn.1001-7097.2017.10.008 (2017).
Wang, D., Feng, R., Shi, S., Wei, N. & Hu, Y. Research progress of oxidative stress associated with CD36 in atherosclerosis. J. Cardiovasc. Cerebrovasc. Dis. Integr. Traditional Chin. Western Med. 20, 1015–1020 (2022).
Hou, Y. et al. Research progress on the role of oxidative stress in the pathogenesis of atherosclerosis. J. Xinxiang Med. Coll. 38, 1090–1094 (2021).
Zeng, Z., Li, G., Wu, S. & Wang, Z. Role of pyroptosis in cardiovascular disease. Cell. Prolif. 52, e12563. https://doi.org/10.1111/cpr.12563 (2019).
Xu, J. et al. Relationship between macrophage apoptosis and plaque vulnerability in atherosclerotic plaques. J. Coll. Military Med. Train. 29, 289–291 (2008).
Liu, Y. et al. Iron death is involved in atherosclerosis induced by high-fat diet and foam cell formation induced by ox-LDL in ApoE-/- mice. J. Practical Med. 37, 585–590. https://doi.org/10.3969/j.issn.1006-5725.2021.05.006 (2021).
Hoseini, Z. et al. NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. J. Cell. Physiol. 233, 2116–2132. https://doi.org/10.1002/jcp.25930 (2018).
Broz, P. & Immunology Caspase target drives pyroptosis. Nature 526, 642–643. https://doi.org/10.1038/nature15632 (2015).
Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665. https://doi.org/10.1038/nature15514 (2015).
Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153–158. https://doi.org/10.1038/nature18629 (2016).
Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111–116. https://doi.org/10.1038/nature18590 (2016).
Evavold, C. L. et al. The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages. Immunity 48 (e36), 35–44. https://doi.org/10.1016/j.immuni.2017.11.013 (2018).
Wang, K. et al. Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis. Cell 180 (e920), 941–955. https://doi.org/10.1016/j.cell.2020.02.002 (2020).
Humphries, F. et al. Succination inactivates gasdermin D and blocks pyroptosis. Science 369, 1633–1637. https://doi.org/10.1126/science.abb9818 (2020).
Barnett, K. C., Ting, J. P., Mitochondrial, G. S. D. M. D. & Pores DAMPen Pyroptosis Immunity 52, 424–426, doi:https://doi.org/10.1016/j.immuni.2020.02.012. (2020).
Virmani, R. et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler. Thromb. Vasc Biol. 25, 2054–2061. https://doi.org/10.1161/01.ATV.0000178991.71605.18 (2005).
Luttun, A. et al. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109, 1408–1414. https://doi.org/10.1161/01.CIR.0000121728.14930.DE (2004).
Ezzahiri, R., Stassen, F. R. M., Kurvers, H. R. M., Dolmans, V. & Bruggeman, C. A. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P. APMIS 114, 117–126. https://doi.org/10.1111/j.1600-0463.2006.apm_205.x (2006).
Do, G. M. et al. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem. Biophys. Res. Commun. 374, 55–59. https://doi.org/10.1016/j.bbrc.2008.06.113 (2008).
Chen, B. Study on the protective effect of berberine oxide on mice with acute lung injury (Guangzhou University of Chinese Medicine, 2021).
Hu, Y. Research progress on the transduction mechanism of mTOR and STAT3, the key signal pathways of resveratrol in the treatment of atherosclerosis. J. Kunming Med. Univ. 34, 164–168 (2013).
Rahmani, S. et al. Berberis vulgaris Fruit Extract Improves Lipid Profile in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. J. Ethnopharmacol. 316, 116872 (2023).
Zhang, Y. et al. Berberine Inhibits Atherosclerotic Plaque Progression by Suppressing Macrophage Foam Cell Formation via the ABCA1/APOA1 Pathway. Int. J. Mol. Sci. 23, 14890 (2022).
Singh, R. et al. Alkaloids from Berberis aristata Mitigate LPS-Induced Inflammation via TLR4/NF-κB Pathway Inhibition. Phytomedicine 112, 154890 (2023).
Cui, J., Chen, X., Sun, Z. & Zhang, H. Extraction of alkaloids from Solanum lyratum Thunb. and its antibacterial activity in vitro. Journal traditional Chin. veterinary medicine 2004,, 41–42, doi:https://doi.org/10.3969/j.issn.1000-6354.2004.05.022. (2004).
Funding
The authors appreciate financial support from the funding of the Natural Science Foundation for Distinguished Young Scholars of Xinjiang Autonomous Region (2025D01E32); Tianshan Talents-Youth Science and Technology Innovation Talents Training Program of Xinjiang Autonomous Region (2022TSYCCX0035); ; Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology (XJDX1713); Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices (2023); Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education (2023).
Author information
Authors and Affiliations
Contributions
Conceptualization, S.A. and D.D.; methodology, S.A.; software, D.D; validation, S.A.; formal analysis, S.A. and D.D.; investigation, W.Z. and A.W.; data curation, S.A.; writing—original draft preparation, S.A.; writing—review and editing, W.Z. and A.W.; visualization, W.Z.; supervision, W.Z. and A.W.; project administration, W.Z.; funding acquisition, W.Z. All authors have read and agreed to the published version of the manuscript. Figure 12 in the manuscript was drawn in Figdraw.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Ainiwaer, S., Dilimulati, D., Wumaier, A. et al. Qualitative analysis of chemical components in Berberis kaschgarica Rupr. and study on the in vitro anti-inflammatory effects of its alkaloids. Sci Rep (2026). https://doi.org/10.1038/s41598-026-41856-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-41856-x
